Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills Candida albicans

• Published in: International journal of molecular sciences Vol. 22; no. 10; p. 5219
• Main Authors: Suchodolski, Jakub, Muraszko, Jakub, Bernat, Przemysław, Krasowska, Anna
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 14.05.2021; MDPI
• Subjects: Acids; Antifungal agents; Candida albicans; Candidiasis; Carbon; Cdr1; CDR1 gene; Complementarity-determining region 1; ERG11 gene; Ergosterol; Fluconazole; Fungicides; Gene expression; Glucose; Infections; lactate; Lactic acid; Localization; Membranes; Opportunist infection; Sterols; Synergistic effect; Vagina; Xenobiotics
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22105219

Candida albicans is an opportunistic pathogen that induces vulvovaginal candidiasis (VVC), among other diseases. In the vaginal environment, the source of carbon for C. albicans can be either lactic acid or its dissociated form, lactate. It has been shown that lactate, similar to the popular antifungal drug fluconazole (FLC), reduces the expression of the ERG11 gene and hence the amount of ergosterol in the plasma membrane. The Cdr1 transporter that effluxes xenobiotics from C. albicans cells, including FLC, is delocalized from the plasma membrane to a vacuole under the influence of lactate. Despite the overexpression of the CDR1 gene and the increased activity of Cdr1p, C. albicans is fourfold more sensitive to FLC in the presence of lactate than when glucose is the source of carbon. We propose synergistic effects of lactate and FLC in that they block Cdr1 activity by delocalization due to changes in the ergosterol content of the plasma membrane.